+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Precision and Personalized Medicine in Pharma - Thematic Intelligence - Product Thumbnail Image

Precision and Personalized Medicine in Pharma - Thematic Intelligence

  • Report
  • June 2023
  • 62 Pages
  • Global
From
Hereditary Angioedema - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hereditary Angioedema - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Hemophilia Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hemophilia Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 98 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Bleeding Disorders Treatment - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorders Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Rare Hematology - Global Strategic Business Report - Product Thumbnail Image

Rare Hematology - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Global Markets for Blood Plasma Products - Product Thumbnail Image

Global Markets for Blood Plasma Products

  • Report
  • February 2023
  • 144 Pages
  • Global
From
Blood Banking and Blood Products - Global Strategic Business Report - Product Thumbnail Image

Blood Banking and Blood Products - Global Strategic Business Report

  • Report
  • November 2024
  • 357 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
Antidotes Global Market Report 2024 - Product Thumbnail Image

Antidotes Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Rare Diseases Treatment Global Market Report 2024 - Product Thumbnail Image

Rare Diseases Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • July 2023
  • 260 Pages
  • Global
From
Alpha-1 Antitrypsin Drugs - Global Strategic Business Report - Product Thumbnail Image

Alpha-1 Antitrypsin Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Alpha 1 Antitrypsin Deficiency Treatment - Global Strategic Business Report - Product Thumbnail Image

Alpha 1 Antitrypsin Deficiency Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Biobetters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Biobetters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 242 Pages
  • Global
Kidney Transplant Global Market Report 2024 - Product Thumbnail Image

Kidney Transplant Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028 - Product Thumbnail Image

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Forecast to 2028

  • Report
  • September 2023
  • 374 Pages
  • Global
From
Electric Wheelchair Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Electric Wheelchair Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 181 Pages
  • Global
From
Loading Indicator